IPCA LABORATORIES LTD (IPCALAB) financials

IPCA LABORATORIES LTD (IPCALAB) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Ipca Laboratories is an integrated pharmaceutical company manufacturing branded and generic formulations, APIs and intermediates. Indian branded formulations are its core profit engine, complemented by formulation exports across Europe, Africa, the Americas, Asia, CIS and Australasia. The consolidated business includes Unichem Laboratories and its US, Brazil, Europe and South Africa operations.[1]

Market Cap: ₹46,494Cr.
Current Price: ₹1,833
Stock P/E: 36.7
ROE: 15.3%
ROCE: 19.7%
Book Value: ₹315
Dividend Yield: 0.33%
52W High / Low: ₹2,039/1,252

In Jun 2026, IPCA LABORATORIES LTD (IPCALAB) reported sales ₹2,119 Cr and net profit ₹373 Cr.

Annual TTM: sales ₹7,709 Cr, net profit ₹1,244 Cr.

Shareholding: Promoters 44.72% (Sep 2026), FIIs 11.53% (Sep 2026), DIIs 36.60% (Sep 2026), Government 0.00% (Sep 2026), Public 7.15% (Sep 2026).

IPCALAB quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	1,811	1,663	1,638	1,747	1,930	1,845	1,814	2,119
Expenses	1,409	1,252	1,280	1,340	1,466	1,368	1,383	1,542
Operating Profit	402	411	359	407	465	477	431	578
OPM %	22%	25%	22%	23%	24%	26%	24%	27%
Other Income	17	17	-260	25	22	18	-1	17
Interest	17	10	16	12	11	10	10	5
Depreciation	63	63	65	63	67	69	70	75
Profit before tax	339	356	17	357	408	417	350	515
Tax %	28%	25%	479%	27%	25%	27%	25%	28%
Net Profit	244	268	-65	262	305	303	262	373
EPS in Rs	9.62	10.55	-2.56	10.33	12.01	11.96	10.34	14.71
Raw PDF	—	—	—	—	—	—	—	—

IPCALAB profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	4,338	5,114	5,405	5,775	6,124	6,635	7,289	7,709
Expenses	3,419	3,596	4,164	4,858	4,909	5,106	5,503	5,758
Operating Profit	918	1,518	1,241	917	1,215	1,529	1,786	1,951
OPM %	21%	30%	23%	16%	20%	23%	24%	25%
Other Income	64	61	53	108	-23	-212	60	57
Interest	19	11	10	46	123	65	45	36
Depreciation	179	188	210	229	246	252	269	280
Profit before tax	785	1,380	1,074	750	822	1,000	1,532	1,691
Tax %	17%	17%	20%	33%	35%	35%	26%	—
Net Profit	652	1,141	860	506	530	651	1,133	1,244
EPS in Rs	25.82	44.97	33.91	19.93	20.91	25.65	44.64	49.02
Dividend Payout %	10%	9%	12%	20%	19%	16%	13%	—

IPCALAB balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	25	25	25	25	25	25	25	25
Reserves	3,111	3,652	4,727	5,450	5,852	6,323	6,866	7,954
Borrowings	444	474	236	776	1,440	1,152	906	295
Other Liabilities	877	1,033	1,021	1,186	1,129	1,159	1,273	1,501
Total Liabilities	4,458	5,185	6,010	7,438	8,447	8,659	9,071	9,776
Fixed Assets	1,740	1,841	1,869	2,153	2,479	2,524	2,537	2,969
CWIP	66	84	182	297	123	175	490	459
Investments	322	649	868	1,339	1,057	2,654	2,693	2,536
Other Assets	2,329	2,611	3,092	3,650	4,789	3,306	3,351	3,810
Total Assets	4,458	5,185	6,010	7,438	8,447	8,659	9,071	9,776

IPCALAB cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	496	561	1,096	832	762	831	1,374	1,378
Cash from Investing Activity	-123	-499	-560	-812	-710	-1,355	-739	-697
Cash from Financing Activity	-223	-139	-307	426	506	-465	-428	-745
Net Cash Flow	150	-76	229	446	559	-990	207	-64
Free Cash Flow	430	301	749	384	362	474	776	718
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	87%	77%	88%	82%	107%	91%	111%	99%

IPCALAB shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	44.72%	44.72%	44.72%	44.72%	44.72%	44.72%	44.72%	44.72%
FIIs	11.06%	10.75%	10.67%	10.42%	10.62%	10.63%	10.72%	11.53%
DIIs	35.36%	35.73%	35.88%	36.45%	36.99%	37.13%	37.04%	36.60%
Government	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.00%
Public	8.53%	8.45%	8.41%	8.09%	7.33%	7.21%	7.19%	7.15%
No. of Shareholders	90,189	88,306	85,582	82,870	77,673	82,184	82,060	90,514

IPCALAB key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	64	71	55	56	59	61	64	64
Inventory Days	332	312	350	364	293	309	297	336
Days Payable	146	133	121	101	80	78	93	119
Cash Conversion Cycle	250	250	284	319	272	293	269	280
Working Capital Days	93	91	108	105	74	87	85	93
ROCE %	17%	20%	30%	19%	11%	14%	17%	20%

IPCALABUpdated 19 Oct 2026, 5:37

Ipca Laboratories Ltd

IPCALABUpdated 19 Oct 2026, 5:37

Market Cap

₹46,494Cr.

Current Price

₹1,833

High / Low

₹2,039/1,252

Stock P/E

36.7

ROE15.3%

ROCE19.7%

Book Value₹315

Face Value₹1.00

Dividend Yield0.33%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	1486	31	1189	43	60	250	33	167	6.57
Sep 2023	1663	39	1314	-3	61	245	34	162	6.39
Dec 2023	1507	27	1234	17	63	200	32	137	5.4
Mar 2024	1511	24	1218	-79	62	127	49	65	2.55
Jun 2024	1566	19	1213	15	61	288	29	204	8.05
Sep 2024	1811	17	1409	17	63	339	28	244	9.62
Dec 2024	1663	10	1252	17	63	356	25	268	10.55
Mar 2025	1638	16	1280	-260	65	17	479	-65	-2.56
Jun 2025	1747	12	1340	25	63	357	27	262	10.33
Sep 2025	1930	11	1466	22	67	408	25	305	12.01
Dec 2025	1845	10	1368	18	69	417	27	303	11.96
Mar 2026	1814	10	1383	-1	70	350	25	262	10.34
Jun 2026	2119	5	1542	17	75	515	28	373	14.71

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	3088	29	2556	32	177	358	28	256	10.15
Mar 2016	2804	31	2526	26	161	111	17	93	3.67
Mar 2017	3102	26	2666	19	171	258	27	188	7.46
Mar 2018	3193	27	2748	39	174	283	18	233	9.24
Mar 2019	3606	21	2909	54	172	557	18	455	18
Mar 2020	4338	19	3419	64	179	785	17	652	25.82
Mar 2021	5114	11	3596	61	188	1380	17	1141	44.97
Mar 2022	5405	10	4164	53	210	1074	20	860	33.91
Mar 2023	5775	46	4858	108	229	750	33	506	19.93
Mar 2024	6124	123	4909	-23	246	822	35	530	20.91
Mar 2025	6635	65	5106	-212	252	1000	35	651	25.65
Mar 2026	7289	45	5503	60	269	1532	26	1133	44.64
TTM	7709	36	5758	57	280	1691	—	1244	49.02

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	44.72%
FIIs	11.53%
DIIs	36.6%
Public	7.15%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	46.29%	10.27%	34.19%	0.32%	8.93%
Mar 2024	46.3%	10.51%	34.05%	0.32%	8.82%
Jun 2024	46.3%	10.85%	33.46%	0.32%	9.07%
Sep 2024	46.3%	10.83%	33.9%	0.32%	8.64%
Dec 2024	44.72%	11.06%	35.36%	0.32%	8.53%
Mar 2025	44.72%	10.75%	35.73%	0.32%	8.45%
Jun 2025	44.72%	10.67%	35.88%	0.32%	8.41%
Sep 2025	44.72%	10.42%	36.45%	0.32%	8.09%
Dec 2025	44.72%	10.62%	36.99%	0.32%	7.33%
Mar 2026	44.72%	10.63%	37.13%	0.32%	7.21%
Jun 2026	44.72%	10.72%	37.04%	0.32%	7.19%
Sep 2026	44.72%	11.53%	36.6%	0%	7.15%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	25	2208	929	662	3824	1753	267	82	1722	3824
Mar 2016	25	2258	865	756	3905	1977	129	97	1702	3905
Mar 2017	25	2450	716	777	3968	1946	95	212	1716	3968
Mar 2018	25	2670	628	785	4108	1855	73	216	1964	4108
Mar 2019	25	3111	444	877	4458	1740	66	322	2329	4458
Mar 2020	25	3652	474	1033	5185	1841	84	649	2611	5185
Mar 2021	25	4727	236	1021	6010	1869	182	868	3092	6010
Mar 2022	25	5450	776	1186	7438	2153	297	1339	3650	7438
Mar 2023	25	5852	1440	1129	8447	2479	123	1057	4789	8447
Mar 2024	25	6323	1152	1159	8659	2524	175	2654	3306	8659
Mar 2025	25	6866	906	1273	9071	2537	490	2693	3351	9071
Mar 2026	25	7954	295	1501	9776	2969	459	2536	3810	9776

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	455	-686	255	25
Mar 2016	696	-214	-414	68
Mar 2017	271	-146	-156	-31
Mar 2018	324	-119	-130	74
Mar 2019	496	-123	-223	150
Mar 2020	561	-499	-139	-76
Mar 2021	1096	-560	-307	229
Mar 2022	832	-812	426	446
Mar 2023	762	-710	506	559
Mar 2024	831	-1355	-465	-990
Mar 2025	1374	-739	-428	207
Mar 2026	1378	-697	-745	-64

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	42	57	59	68	64	71	55	56	59	61	64	64
Inventory Days	293	290	288	286	332	312	350	364	293	309	297	336
Days Payable	97	145	128	136	146	133	121	101	80	78	93	119
Cash Conversion Cycle	238	203	219	218	250	250	284	319	272	293	269	280
Working Capital Days	69	62	75	82	93	91	108	105	74	87	85	93
ROCE %	13%	4%	9%	9%	17%	20%	30%	19%	11%	14%	17%	20%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of IPCA LABORATORIES LTD (IPCALAB)?

The reported market capitalisation for IPCA LABORATORIES LTD (IPCALAB) is ₹46,494Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of IPCALAB?

The current price shown for IPCA LABORATORIES LTD (IPCALAB) on Fincrux is ₹1,833 with a 52-week high/low of ₹2,039/1,252.

What is the P/E ratio of IPCA LABORATORIES LTD (IPCALAB)?

The stock P/E for IPCA LABORATORIES LTD (IPCALAB) is 36.7 on Fincrux, with ROE at 15.3% and ROCE at 19.7%.

What were IPCALAB latest quarterly results?

For Jun 2026, IPCA LABORATORIES LTD (IPCALAB) reported sales ₹2,119 Cr and net profit ₹373 Cr (figures in ₹ crore unless noted).

What are IPCALAB annual sales and net profit?

For TTM, IPCA LABORATORIES LTD (IPCALAB) shows sales of ₹7,709 Cr and net profit of ₹1,244 Cr on the Fincrux profit & loss statement.

Who owns IPCA LABORATORIES LTD (IPCALAB)?

Latest shareholding for IPCA LABORATORIES LTD (IPCALAB) on Fincrux: Promoters 44.72% (Sep 2026), FIIs 11.53% (Sep 2026), DIIs 36.60% (Sep 2026), Government 0.00% (Sep 2026), Public 7.15% (Sep 2026).

Where can I find IPCA LABORATORIES LTD (IPCALAB) financials?

IPCA LABORATORIES LTD (IPCALAB) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show IPCALAB balance sheet and cash flow?

Yes. The IPCA LABORATORIES LTD (IPCALAB) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 5:37